FI64899C - Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial - Google Patents

Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial Download PDF

Info

Publication number
FI64899C
FI64899C FI782501A FI782501A FI64899C FI 64899 C FI64899 C FI 64899C FI 782501 A FI782501 A FI 782501A FI 782501 A FI782501 A FI 782501A FI 64899 C FI64899 C FI 64899C
Authority
FI
Finland
Prior art keywords
polymer
core material
solvent
microcapsules
isopropanol
Prior art date
Application number
FI782501A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI64899B (fi
FI782501A7 (fi
Inventor
Jones Wing Fong
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI782501A7 publication Critical patent/FI782501A7/fi
Publication of FI64899B publication Critical patent/FI64899B/fi
Application granted granted Critical
Publication of FI64899C publication Critical patent/FI64899C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28Microcapsules or nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/025Explicitly spheroidal or spherical shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85Polyesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/08Simple coacervation, i.e. addition of highly hydrophilic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/624Coated by macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/654The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Environmental Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
FI782501A 1977-08-25 1978-08-16 Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial FI64899C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82771077A 1977-08-25 1977-08-25
US82771077 1977-08-25

Publications (3)

Publication Number Publication Date
FI782501A7 FI782501A7 (fi) 1979-02-26
FI64899B FI64899B (fi) 1983-10-31
FI64899C true FI64899C (fi) 1984-02-10

Family

ID=25249947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782501A FI64899C (fi) 1977-08-25 1978-08-16 Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial

Country Status (21)

Country Link
JP (1) JPS5455717A (de)
AT (1) AT372019B (de)
AU (1) AU522215B2 (de)
BE (1) BE869915A (de)
CA (1) CA1122077A (de)
CH (2) CH649217A5 (de)
DE (1) DE2836044A1 (de)
DK (2) DK361878A (de)
ES (1) ES472800A1 (de)
FI (1) FI64899C (de)
FR (1) FR2400950A1 (de)
GB (1) GB2003108B (de)
IE (1) IE47255B1 (de)
IL (1) IL55418A (de)
IT (1) IT1098111B (de)
NL (1) NL7808613A (de)
NZ (1) NZ188232A (de)
PH (1) PH15447A (de)
PT (1) PT68473A (de)
SE (1) SE431942B (de)
ZA (1) ZA784855B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
JPS5933214A (ja) * 1982-08-19 1984-02-23 Mitsui Toatsu Chem Inc 微小球に製剤された制ガン剤の製造方法
AT382076B (de) * 1982-10-15 1987-01-12 Chemie Linz Ag Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
DE3417576A1 (de) * 1984-05-11 1985-11-14 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung
DE3428372A1 (de) * 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
CH660302A5 (fr) * 1984-10-17 1987-04-15 Debiopharm Sa Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
CH669506A5 (en) * 1986-01-13 1989-03-31 Hugo Degen Oscillating and reclining furniture
DE3712095A1 (de) * 1987-04-10 1988-10-20 Lentia Gmbh Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
FR2657255B1 (fr) * 1989-12-27 1992-04-24 Sederma Sa Description de preparations cosmetiques originales dont les principes actifs sont pieges dans un reseau polymerique greffe a la surface de particules de silice.
DE4127757A1 (de) * 1991-02-06 1992-08-13 Hoechst Ag Neue pflanzenschutzmittel-formulierungen
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
US6969480B2 (en) 2000-05-12 2005-11-29 Matregen Corp. Method of producing structures using centrifugal forces
US6787090B2 (en) 2000-05-12 2004-09-07 Matregen Corp. Method of producing structures using centrifugal forces
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
EP2219775A4 (de) * 2007-12-11 2012-10-03 Univ Nanyang Tech Mehrschichtige hohle mikrokügelchen für die freisetzung hydrophiler wirkstoffe
JP5099135B2 (ja) * 2008-05-21 2012-12-12 東レ株式会社 ポリマー微粒子の製造方法
CN103828801B (zh) * 2014-01-15 2016-01-27 福建农林大学 多杀菌素/甲氨基阿维菌素苯甲酸盐微球及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT631615A (de) * 1960-02-26
US3427250A (en) * 1963-03-25 1969-02-11 Polaroid Corp Microscopic capsules and process for their preparation
US3531418A (en) * 1965-08-18 1970-09-29 Ncr Co En masse encapsulation process
FR1497584A (fr) * 1966-08-11 1967-10-13 Roussel Uclaf Procédé de fabrication de microcapsules
US3703474A (en) * 1967-08-21 1972-11-21 Ncr Co Encapsulation process
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
JPS51125675A (en) * 1975-02-13 1976-11-02 Asahi Chem Ind Co Ltd A porous capsule structvre and a process for manufacturing turing it

Also Published As

Publication number Publication date
FI64899B (fi) 1983-10-31
ES472800A1 (es) 1979-10-16
FR2400950A1 (fr) 1979-03-23
GB2003108B (en) 1982-03-24
AU3923678A (en) 1980-02-28
BE869915A (fr) 1979-02-23
IL55418A (en) 1981-07-31
DK618189D0 (da) 1989-12-07
FI782501A7 (fi) 1979-02-26
ZA784855B (en) 1980-04-30
ATA612478A (de) 1983-01-15
IL55418A0 (en) 1978-10-31
NL7808613A (nl) 1979-02-27
DK361878A (da) 1979-02-26
PT68473A (fr) 1978-09-01
NZ188232A (en) 1980-12-19
IE47255B1 (en) 1984-02-08
IE781708L (en) 1979-02-25
FR2400950B1 (de) 1983-10-07
AU522215B2 (en) 1982-05-20
AT372019B (de) 1983-08-25
PH15447A (en) 1983-01-18
JPS645005B2 (de) 1989-01-27
GB2003108A (en) 1979-03-07
SE7808759L (sv) 1979-02-26
IT1098111B (it) 1985-09-07
DK618189A (da) 1989-12-07
DE2836044C2 (de) 1988-06-23
CH644768A5 (de) 1984-08-31
CH649217A5 (de) 1985-05-15
JPS5455717A (en) 1979-05-04
CA1122077A (en) 1982-04-20
IT7826961A0 (it) 1978-08-23
SE431942B (sv) 1984-03-12
DE2836044A1 (de) 1979-03-01

Similar Documents

Publication Publication Date Title
FI64899C (fi) Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial
US4166800A (en) Processes for preparation of microspheres
Singh et al. Microencapsulation: A promising technique for controlled drug delivery
Agnihotri et al. Microencapsulation–a novel approach in drug delivery: a review
Dhakar et al. Variables influencing the drug entrapment efficiency of microspheres: A pharmaceutical review
Streubel et al. Floating microparticles based on low density foam powder
AU699080B2 (en) Sustained release particles
JP3179132B2 (ja) 非粘着性皮膜形成法
Kondo et al. Preparation of sustained-release coated particles by novel microencapsulation method using three-fluid nozzle spray drying technique
Khandbahale Microencapsulation-A novel approach in drug delivery: A review
Abulateefeh et al. Synthesis and characterization of PLGA shell microcapsules containing aqueous cores prepared by internal phase separation
CN101940554A (zh) 一种用于负载水溶性小分子药物的多核芯粘附微球及其制备方法
Riekes et al. Development and evaluation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone microparticles of nimodipine
Seo et al. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres
Jelvehgari et al. Preparation and determination of drug-polymer interaction and in-vitro release of mefenamic acid microspheres made of celluloseacetate phthalate and/or ethylcellulose polymers
Krishna et al. A review on microsphere for novel drug delivery system
Singh et al. Sustained drug delivery using mucoadhesive microspheres: the basic concept, preparation methods and recent patents
Chaware et al. Bioadhesive microspheres: a review on preparation and in-vitro characterization
JPH0372097B2 (de)
Sun et al. Research progress on temperature-controlled release microcapsules
Fetih Formulation and characterization of Gelucire pellets for sustained release of Ibuprofen
Pathan et al. A SHORT REVIEW ON MICROSPHERE.
Mohapatra et al. EFFECT OF PREPARATION TEMPERATURE ON ETHYLCELLULOSE MICROSPHERE PROPERTIES PREPARED BY OIL-IN-OIL EMULSION SOLVENT EVAPORATION PROCESS.
JPH0624964A (ja) ヒドロモルホンスフェロイド調整放出製剤
Surendra et al. Review on Microencapsulation Drug delivery Systems

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG